bpc-157 clinical evidence safety review Frontiers The Stable Gastric Pentadecapeptide BPC

$200.00 Research Use Only Comprehensive Research Overview AHK-Cu 200mg (Topical) is a precision-engineered synthetic copper-binding research peptide supplied by BioPeptides for advanced in-vitro laboratory investigation

The skin is cleansed with a sterilizing solution (chlorhexidine) and a sterile drape is placed

The next day I am more calm as well

The Clinic staff are wonderful

This injection plays a significant role in the preservation of the nervous system and red blood cells

Other side effects Additional reported side effects include: Joint pain and water retention Muscle and joint aches Headaches and nausea Receptor desensitization with prolonged use Potential suppression of natural GH and IGF-1 production Who should avoid IGF-1 LR3 Certain groups should not use IGF-1 LR3: Anyone with active cancer or tumor history Those with severe insulin resistance or diabetes Pregnant or nursing women Anyone under 25 whose growth plates haven't closed Those with existing hormonal imbalances IGF-1 LR3 is not FDA-approved for general medical use and remains primarily a research compound